Search - tctmd.com

Displaying 81 - 100 of 234

Sort: Relevancy | Date

News Daily News

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

L.A. McKeown

June 01, 2022

News Conference News EAS 2022

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Michael O'Riordan

May 24, 2022

News Daily News

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

Michael O'Riordan

May 09, 2022

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

News Daily News

SCAI-Led Position Statement on CLTI Spotlights Multispeciality Involvement

L.A. McKeown

April 27, 2022

News Daily News

MOSAIC: Home Intervention Boosts Walking Time in PAD Patients

L.A. McKeown

April 15, 2022

News Daily News

PAD Significantly Ups Morbidity and Mortality in AMICS

L.A. McKeown

March 29, 2022

News Daily News

Financial Strain Ups Risk of Death After Acute MI in the Elderly

L.A. McKeown

February 25, 2022

News Daily News

Study Touts Benefits of Exercise as Primary CVD Prevention in Older Adults

L.A. McKeown

February 15, 2022

News Daily News

TCTMD’s Top 10 Most Popular Stories for December 2021

Caitlin E. Cox

December 29, 2021

News Daily News

Statins Underprescribed in PAD Before and After Interventions

L.A. McKeown

December 03, 2021

News Daily News

Intravascular Lithotripsy May Facilitate TAVI in Patients With PAD

L.A. McKeown

November 04, 2021

News Conference News VIVA 2021

EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions

L.A. McKeown

October 12, 2021

News Conference News VIVA 2021

Striking Racial Gaps Exist in Care for Peripheral Interventions, Registry Affirms

L.A. McKeown

October 07, 2021

News Conference News VIVA 2021

Vascular Care Falls Short Before Amputation for CLI: Medicare Analysis

L.A. McKeown

October 06, 2021

News Daily News

Survey Addresses Cardiac Rehab Challenges and Future Directions

L.A. McKeown

September 27, 2021

News Opinion CV Team Dispatch

September 2021 News Roundup

L.A. McKeown

September 01, 2021

News Conference News ESC 2021

PRONOUNCE: No Difference in CVD Risks With Degarelix and Leuprolide for Prostate Cancer

Michael O'Riordan

August 30, 2021

News Daily News

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

L.A. McKeown

August 10, 2021

News Daily News

PAD Continues to Elude Clinicians, Despite Gains: AHA

L.A. McKeown

August 05, 2021

Advertisement

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

Good News and Bad for High-Intensity Statin Use in ASCVD

SCAI-Led Position Statement on CLTI Spotlights Multispeciality Involvement

MOSAIC: Home Intervention Boosts Walking Time in PAD Patients

PAD Significantly Ups Morbidity and Mortality in AMICS

Financial Strain Ups Risk of Death After Acute MI in the Elderly

Study Touts Benefits of Exercise as Primary CVD Prevention in Older Adults

TCTMD’s Top 10 Most Popular Stories for December 2021

Statins Underprescribed in PAD Before and After Interventions

Intravascular Lithotripsy May Facilitate TAVI in Patients With PAD

EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions

Striking Racial Gaps Exist in Care for Peripheral Interventions, Registry Affirms

Vascular Care Falls Short Before Amputation for CLI: Medicare Analysis

Survey Addresses Cardiac Rehab Challenges and Future Directions

September 2021 News Roundup

PRONOUNCE: No Difference in CVD Risks With Degarelix and Leuprolide for Prostate Cancer

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

PAD Continues to Elude Clinicians, Despite Gains: AHA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content